500 posts

21 March

AJKD https://www.ajkd.org/

10:30
18 ‘Nectar' Induced Oxalate Nephropathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
17 Hot and Muggy Marathon: A Potent Recipe for Rhabdo AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
16 BRASH Syndrome: An Under-Recognized Syndrome in Patients With Renal Failure AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
15 Ghost Toxicity and Acute Kidney Injury AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
14 Understanding Symptoms and Quality-of-Life of Patients With AKI-D AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
13 Distinct Subgroups of Patients Identified-based on Health Utility in Early Acute Kidney Injury Using Latent Class Analysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
12 Rhabdomyolysis: A Lesser-Known Complication of Hyperosmolar Hyperglycemic Coma AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
11 COVID-19-related Acute Kidney Injury: Incidence, Risk Factors and Outcome in a County Hospital Cohort AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
10 Treatment-Related Cost Analysis for Adults With Hepatorenal Syndrome With Rapid Reduction in Kidney Function AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
9 Overlooked Sulfonamide Induced Nephropathy in Cirrhotic Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
8 Vancomycin-associated Nephrotoxicity AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
7 The Utility of POCUS Enhanced Physical Examination in the Management of Cardiorenal Syndrome AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
6 Hepatorenal Syndrome in a Patient With Fulminant Hepatic Failure From Hepatitis A AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
5 Acute Kidney Injury With Thrombotic Microangiopathy in a Patient With Hemophagocytic Lymphohistiocytosis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
4 Sodium Bicarbonate Use in Severe Rhabdomyolysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
3 An Uncommon Presentation of Cocaine-Induced Acute Interstitial Nephritis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
2 “Hidden in plAIN sight”: A Case Report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
1 A Case of AKI in a Patient With Tianeptine Toxicity AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
71 A Unique Case of Membranous Nephropathy and Proteinuria in a Patient With Common Variable Immunodeficiency Syndrome AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
70 Propofol Related Infusion Syndrome With Multifactorial Associated Metabolic Acidosis and Rhabdomyolysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
69 Prolonged Bile Cast Nephropathy Following Orthotopic Liver Transplant, a Diagnostic and Management Challenge AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
68 Unexplained Hyperphosphatemia in Relapsed AML Patient Undergoing Investigational Therapy. A Diagnostic Enigma AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
67 Ask-Upmark Kidney: A Forgotten Entity AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
66 Hypercalcemia, Tertiary Hyperparathyroidism and Beyond AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
65 Complex ICHD Patient Improves With Tailored Nutrition Regimen AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
64 Successful Rescue of Allograft Kidney via Thrombolysis and Mechanical Thrombectomy After Provoked DVT Causing Anuria AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
63 Rosehip Tea, a Rare Cause of Acute Interstitial Nephritis: A Case Report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
62 From Soil to the Peritoneum: Fungal Peritonitis With Paecilomyces Variotii AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
61 Transient Proximal Renal Tubular Dysfunction, Fanconi Syndrome, Associated With Salicylate Poisoning AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
60 Collagenofibrotic Glomerulopathy (Collagen Type III Glomerulopathy) Associated With a Bleeding Diathesis: A Case Report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
59 Calciphylaxis Progressing to Necrotizing Fasciitis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
58 Congophilic Fibrillary Glomerulonephritis: A Case of Natural History AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
57 Infection-related Glomerulonephritis Associated With Campylobacter jejuni Enteritis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
56 Delayed Seropositive Lupus Nephritis: A Clinical Dilemma AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
55 A Case of Syndrome of Inappropriate Mineralocorticoid Excess Secondary to Licorice Toxicity via Over-the-Counter Supplement AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
54 Primary PLA2Rab Positive Membranous Nephropathy With Concomitant Pancreatic Cancer AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
53 Not Every Amyloidosis is Proteinuric: Unusual AL Amyloidosis Deposition AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
52 Do No Harm: Is It Really Idiopathic MPGN? AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
51 An Unusual Kidney Mass: A Hematologic Double Hit AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
50 Hyperleukocytosis, Hyperkalemia and AKI: Tumor Lysis Syndrome, Or Is It? AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
49 Ifosfamide- vs Brentuximab Vedotin-Induced Karyomegalic-like Interstitial Nephritis (KIN)? AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
48 Sjogren’s Nephritis With Glomerular and Tubulointerstitial Disease Responsive to Prednisone AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
47 C3 Glomerulopathy and Thrombotic Microangiopathy: Two Diseases, Same Pathogenesis - A Case Report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
46 Horseshoe Kidney Complicated by BPH, Recurrent Urinary Tract Infections and Progressive Renal Dysfunction AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
45 Follow-up Post Renal Transplant From Deceased Donor With Gitelman Syndrome AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
44 Acute Interstitial Nephritis Causing Hypokalemia and Diabetes Insipidus AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
43 A Case of Waldenstrom's Macroglobulinemia Causing Type 1 Cryoglobulinemic Glomerulonephritis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
42 Vancomycin-Related Leukocytoclastic Vasculitis With Worsening AKI AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
41 A Rare Case of Acute Kidney Injury (AKI) With IgG-4 Related Disease (RD) Without Extra Renal Manifestations AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
40 Renal Thrombotic Microangiopathy in a Patient With Systemic Lupus Erythematous AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
39 A Subtle Presentation of Acute Interstitial Nephritis With a Peculiar Etiology AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
38 Vancomycin and Piperacillin Induced Acute Interstitial Nephritis in a Patient With Lupus: A Case Report Showcasing Rapid Decline in Renal Function AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
37 Percutaneous Renal Biopsy in a Pregnant Patient: Taking a Different Approach AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
36 A Rare Case of Recurrent UTIs and Hearing Loss Caused by Heterozygous Deletion of GATA 3 Gene AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
35 Abiraterone Acetate, An Unusual Culprit of Severe Hypokalemia, a Case Report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
34 Outcome Comparison in Hospitalized COVID-19 Patients With and Without AKI AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
33 Distinct Subtypes of Hepatorenal Syndrome and Associated Outcomes as Identified by Machine Learning Consensus Clustering AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
32 Disease Modifying Anti-Rheumatic Drugs As a Cause of IgA Nephropathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
31 Serum Lactate at Presentation and Acute Kidney Injury in Intermediate and High Risk Pulmonary Embolism Presenting at an Academic Tertiary Care Center AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
30 Cancer-Associated TMA AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
29 Lifesaving Molecular Adsorbent Recirculating System Use in a Young Female With Unintentional Liver Failure AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
28 An Interesting Case of Anti-Glomerular Basement Membrane Disease Mediated by IgA Autoantibodies AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
27 In Vitro Drug Interaction Studies of UNI-494 Indicate Low Risk of Drug-Drug Interactions AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
26 UNI-494 Lowers Urine Beta-2-microglobulin in Rats AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
25 Immune Complex Mediated Proliferative Glomerulonephritis Associated With Avelumab and COVID-19 Infection AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
24 A Case of Chronic Interstitial Nephritis From an Infiltrative Renal B-cell Lymphoma AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
23 Improving Post-AKI Care: A QI Approach AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
22 Cystatin C as an Early Marker of Kidney Recovery in a Patient With AKI and Rhabdomyolysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
21 Four-Year Account of Renal and Mortality Outcomes After Elective Discontinuation of Long-Term RAAS Blockade in CKD Patients With Otherwise Inexplicable Progressive New-Onset Acute Kidney Injury AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
20 A Reduction in Serum Creatinine of at Least 30% Leads to Meaningful Clinical Outcomes in Patients with Hepatorenal Syndrome Type 1: A Pooled Analysis of 3 Phase III Studies AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
19 Risk Factors for Acute Kidney Injury (AKI) Requiring Dialysis in Patients With and Without Chronic Kidney Disease (CKD), During an Admission for Pneumonia Using a Nationally Representative Sample AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
127 There is a Blood Leak in the CRRT? AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
126 Urine Organic Acid Testing, Exposing an Unexpected Gap AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
125 A Case of Thin Basement Membrane Nephropathy Presenting With Secondary FSGS AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
124 Newly Diagnosed Renal Sarcoidosis in a Young Male AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
123 Interstitial Nephritis following Tislelizumab: A Case Report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
122 An Atypical Presentation of AA Amyloidosis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
121 Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits in a Young Female AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
120 Central Retinal Vein Occlusion in a Patient with Biopsy Proven C3GN AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
119 Refractory Hypercalcemia: The Role of Rapid Correction Through Hemodialysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
118 Hydralazine-Induced Full House Pattern Glomerulonephritis in a Kidney Transplant Recipient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
117 Don't Know Why I'm So Tired: Intravenous Iron Replacement A Recipe For Persistent Hypophosphatemia AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
116 Hereditary Angiopathy with Nephropathy, Aneurysms and Muscle Cramps (HANAC) Syndrome in a Patient with Polycystic Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
115 Renal Atheroembolic Disease Mimicking Interstitial Nephritis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
114 Encephalopathy Due To Baclofen in End Stage Renal Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
113 Early Onset Adulthood PR3 ANCA Vasculitis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
112 Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits, IgG3 Lambda: No Age Is "Immune" AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
111 Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits: A Case Report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
110 IgA Nephropathy With c-ANCA Positivity in a Patient With Crohn's Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
109 A Case of Acquired Thrombotic Thrombocytopenic Purpura Following Near-Drowning AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
108 Pre-bariatric Surgery Acute Kidney Injury: Can This Be Prevented? AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
107 Tacrolimus Toxicity in the Setting of Novel KRAS Inhibitor, Adagrasib AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
106 HIVICK Presenting With Malignant Hypertension AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
105 Proximal Renal Tubular Acidosis and Nephrolithiasis in Pregnancy Due to SLC34A1 Gene Mutation AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
104 Silent Presentation of IgG4-Related Disease in a Chronic Kidney Disease Patient: A Case Report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
103 Acute Pancreatitis in a Patient With Malignancy-Induced Hypercalcemia AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
102 Isolated Glycosuria in a Patient With Confirmed SLC5A2 Mutation AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
101 Sporadic Polyarteritis Nodosa Presenting With Ileal Perforation AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
100 Anticoagulant-Related Nephropathy Associated With Atypical ANCA AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
99 Histological and Clinical Anti-GBM Disease With MPO-ANCA but Without Circulating Anti-GBM Antibodies AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
98 Cocaine Induced Acute Kidney Injury From Two Possible Causes: A Case Report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
97 An Uncommon Morphology of Intratubular Light Chain Casts in Multiple Myeloma: Amyloid Cast Nephropathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
96 Granulomatous Interstitial Nephritis in a Transplant Patient With Crohn’s Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
95 The Transition From PD to Home Hemodialysis at Hospital Discharge AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
94 Atypical Hemolytic Uremic Syndrome From Recent Oral Contraceptive Use AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
93 Membranoproliferative Glomerulonephritis With Prostate Cancer: A Rare Paraneopalstic Nephropathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
92 What's My Metformin Formin'?: A Rare Case of Metformin Associated Lactic Acidosis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
91 Beckwith Weideman Syndrome and Renal Cysts: A Case Report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
90 Characterisitc Urine Sediment in Babesia Induced AIN AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
89 A Case of Hemolytic Uremic Syndrome in a Pregnant Woman Requiring Hemodialysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
88 Dialysis-Associated Acute Hypersensitivity During Continuous Renal Replacement Therapy and Hemodialysis: A Case Report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
87 Minimal Change Disease Caused by Alectinib, Never Reported Side Effect of a Novel Agent AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
86 A Unique and Challenging Case of Light Chain Nephropathy With Direct Plasma Cell Infiltration of Renal Tissue AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
85 A Case of C1q Nephropathy Without Co-Deposition of Immunoglobulin G and Free Light Chains AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
84 Acute Kidney Injury in a patient With Metastatic Renal Cell Carcinoma Treated With One Dose of Nivolumab: Case report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
83 Viral Reactivation After HCV-Positive Renal Allograft Transplantation AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
82 Chronic Hepatitis-C Infection and Kidney Failure AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
81 Collapsing Glomerulopathy From Methamphetamine Use AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
80 Gestational Diabetes Insipidus-Induced Refractory Hypokalemia AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
79 Rare Cause of Pseudotumor Cerebri Syndrome (PTS) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
78 A Rare Case of Renal Limited Post-Transplant Lymphoproliferative Disorder (PTLD) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
77 Triphasic Dysnatremia After Neurosurgery AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
76 Trabectedin Associated Acute Kidney Injury: A Two Person Case Series AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
75 Paxlovid-Induced Tacrolimus Toxicity in Kidney Transplant Recipients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
74 Dance Between IgA Vasculitis and Granulomatosis With Polyangiitis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
73 Membranous Nephropathy Secondary to Autoimmune Polyglandular Syndrome AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
72 Early Plasmapheresis: A Viable Treatment Option for Hypertriglyceridemia Induced Acute Pancreatitis in a Pregnant Woman AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
180 Blood Transfusion and Transplant Rates Among Medicare Patients With Dialysis-Dependent CKD and Hyporesponse to ESAs AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
179 Inpatient Admission and Mortality Rates Among Medicare Patients With Dialysis-Dependent CKD and Hyporesponse to ESAs AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
178 The Unexpected Guest: CMV Retinitis Without Viremia in a Kidney Transplant Recipient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
177 Atypical NF1 Diagnosis With Renal Specific Genetic Testing in a Case of Secondary Focal Segmental Glomerulosclerosis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
176 Pauci-Immune ANCA-Positive Crescentic Glomerulonephritis Associated With Metastastatic Clear Cell Ovarian Carcinoma AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
175 Rasburicase Induced Hemolytic Anemia AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
174 Left Renal Vein Entrapment Syndrome (LRVES) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
173 AL Amyloidosis Presenting as Asymptomatic Nephrotic Range Proteinuria in a Patient With Long Standing Diabetes Mellitus AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
172 Not All Those Kidney Cysts are From ADPKD AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
171 Crescentic Lupus Nephritis With Positive Anti-MPO Antibodies in a Patient With Latent Tuberculosis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
170 Radiation Induced Baroreceptor Failure: Importance of Telehealth Blood Pressure Monitoring AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
169 Minimal Change Disease Following Novel COVID-19 Infection: Case Report and Review of Literature AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
168 Victory With Voclosporin: A Case of Complete Remission in Severe Lupus Nephritis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
167 SARS-CoV-2 as a Possible Cause of Persistent Hypophosphatemia in a Patient With End Stage Renal Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
166 Role for Calcineurin Inhibitor in Tyrosine Kinase Inhibitor-Induced Focal Segmental Glomerulosclerosis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
165 Malignant Hypertension Induced Thrombotic Microangiopathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
164 Paraplegia and Hemodialysis Disequilibrium Syndrome AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
163 Lupus like Presentation of Acute Parvovirus B19 Infection With Hypocomplementemia in a Kidney Transplant Recipient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
162 Successful Pregnancies in a Renal Transplant Recipient With Recurring Intrahepatic Cholestasis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
161 Daratumumab Management of Monoclonal Immunoglobulin Deposition Disease (MIDD) in a Second Renal Allograft AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
160 Coexistent Multiple Viremias and Acute Cellular Rejection in a Kidney Transplant Recipient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
159 Crescent Formation: From Fibrillary GN, ANCA-Vasculitis, or Both? AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
158 EBV-Negative Monomorphic Post-Transplant Lymphoproliferative Disorder Associated With Hemophagocytic Lymphohistiocytosis in an Adult Kidney Transplant Recipient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
157 Hypertensive Emergency in a Young Male: Unmasking Silent IgA Nephropathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
156 Linaclotide Induced Oxalate Nephropathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
155 Tertiary Hyperparathyroidism With Lateralization After Remote Serial Parathyroidectomies With Sequential Autotransplantation AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
154 Can Belatacept-Based Regimen Hold the Key to Successful Kidney Transplantation in Patients With Familial Lecithin-Cholesterol Acyltransferase Deficiency Nephropathy? AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
153 Recurrent Collagenofibrotic Glomerulopathy in a Kidney Transplant Recipient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
152 More Than the Tip of the Problem AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
151 A Case of nephrocentric IgG4-related Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
150 APOL-1 Kidney Disease Presenting With Advanced Uremic Chromhidrosis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
149 An Unusual Cause of Renal Amyloidosis: Skin Popping to Renal Failure AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
148 A Unique Case of Targeted Therapy Causing Immune Complex Glomerulonephritis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
147 “Keep Your Eyes Open”: A Case of Recurrent Calciphylaxis Post Kidney Transplant AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
146 Genetic Testing: Complementary or Contradictory to Kidney Biopsy in Evaluation of Patients with Chronic Kidney Disease– A Unique Case AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
145 A Case of Rituximab Rescue Therapy in Class V Lupus Nephritis With Severe Hematological Manifestations AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
144 A Case of Combined Diabetic Ketoacidosis and Lower Limb Amputation in a Patient on SGLT2-Inhibitors AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
143 Is Meso- American Nephropathy (MeN) Only a Disease of Central America? Reporting a Case Series of MeN in Trenton, NJ AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
142 A Case of Hydralazine Induced Severe Renal-Limited ANCA Vasculitis Leading to ESRD in a 63-Year-Old Man AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
141 Covid Induced Rhabdomyolysis Causing Acute Renal Failure and Transaminitis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
140 A Rare Case of Proliferative ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
139 Hyperoxaluria Due to Moonshine Ingestion AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
138 Empyema: An Uncommon Cause for Infection-Related Glomerulonephritis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
137 In Vitro Fertilization-Related Renal Failure AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
136 Malignant Hypertension Induced Thrombotic Microangiopathy in a Patient with Primary Hyperaldosteronism AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
135 Calciphylaxis in a Non-Dialysis Chronic Kidney Disease Patient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
134 Idiopathic Mixed Cryoglobulinemia With Renal Involvement AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
133 An Unusual Case of Fanconi-like Syndrome With Abiraterone AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
132 Resistant Hypertension Secondary to Catecholamine-Secreting Glomus Tumor AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
131 Importance of MAP Reduction for AKI Induction in Type 1 Cardiorenal Syndrome AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
130 Baclofen Toxicity Causing Delirium and Agitation in a Patient With ESRD AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
129 Minimal Change Disease Flare After COVID-19 Infection Requiring Dialysis Support AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
128 Anti-GBM Disease Presenting as Obstructive Uropathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
242 Assessing Chronic Kidney Disease Knowledge, Beliefs, and Risk Among Detroit Residents AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
241 Dementia Knowledge Among Multidisciplinary U.S. Dialysis Care Providers AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
240 Communication Climate Among African American Hemodialysis Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
239 COVID Vaccine Hesitancy and Health Locus of Control in Inner-City Patients With Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
238 Projected Annual Reductions in Central Venous Catheter (CVC)-Related S. aureus Bloodstream Infections (SA-BSIs) and Healthcare Costs (HCs) Associated With SA Nasal Decolonization (SA-ND) in SA Nares Colonized Hemodialysis Patients (SA-NC HD Pts) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
237 Transient Hepatitis B Surface Antigenemia Following Hepatitis B Immunization: Lessons From a Recent Case AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
236 Prevalence of Housing Insecurity and Mortality Among U.S. Veterans With Kidney Failure AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
235 Collective Impact Approach to Improve CKD diagnosis and management: A Show Me CKDintercept Initiative AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
234 Patterns of ‘High-Potency Low-Cost’ NSAID Analgesic Powder Purchasing in the U.S AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
233 Effects of SARS-CoV-2 Vaccination on the Severity of COVID-19 Infection in Patients on Chronic Dialysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
232 Barriers and Facilitators to Implementation of the End-Stage Kidney Disease Life Plan AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
231 Dialysis Care Team Communication Quality by Patient English Proficiency Status AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
230 eGFR Changes During Pegloticase Treatment With and Without Methotrexate Co-therapy: 12-month Findings of MIRROR RCT AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
229 SARS-CoV-2 Reinfection Among Maintenance Dialysis Patients: Report of 471 cases AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
228 Self-reported Eating Problems Among Patients With Chronic Kidney Disease are Associated With Higher Mortality AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
227 Association of Vaccine-induced Serum IgG Antibody and SARS-CoV-2 Infection and Hospitalization/Death Among Dialysis Patients During Omicron Era AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
226 Nephrology Providers’ Perspectives on Terminology Used to Discuss the Option of Forgoing Kidney Replacement Therapy With Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
225 Success of Online CME on Knowledge of CKD-aP AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
224 Self-Reported Physical Activity Among Individuals With Chronic Kidney Disease is Associated With Greater Survival AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
223 Emergency-Only Dialysis and the Impact of Transition to Scheduled Treatment on Patient-Centered Outcomes AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
222 Short-Term Effects of Hemodynamic Instability During Hemodialysis on Cognitive Function Among Hospitalized Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
221 Management of End-Stage Kidney Disease Patients Receiving Emergency Only Hemodialysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
220 Professional Fulfillment and Burnout among Multidisciplinary U.S. Dialysis Providers AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
219 Comparative Effectiveness of Two Different Intradialytic Intervention Programs for Improving Gait and Balance in Individuals Receiving Hemodialysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
218 Assisted Home Hemodialysis Program: A Unique Experience from the State of Qatar AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
217 Patterns of Engagement With Primary Care Services in Patients With ESKD AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
216 Stable and Adherent Patients Receiving Hemodialysis, as Compared to High-Risk Patients, Report Better Quality of Life AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
215 Dialysis Procedure Increases the Risk for Developing Substance Use Disorder in Chronic Kidney Disease Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
214 AquaBplus Double Stage Water Purification System and Water Quality in Hemodialysis Clinics AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
213 Pregnancy and Family Planning in Women With Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
212 Short-Term Cost Impact of Dapagliflozin in Chronic Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
211 Factors Influencing the Attainment of Self-Management Goals Among Underserved Patients Living With or At-Risk for Chronic Kidney Disease (CKD) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
210 Community Initiative to Co-Develop Chronic Kidney Disease Educational Materials for Underserved Latine Adults AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
209 Contrast-Induced Encephalopathy in Patients With CKD and ESKD: A Systematic Review AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
208 Impacts of Broad Panel Genetic Testing on the Management of Patients With Chronic Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
207 Proact 1 and 2 Phase 3 Study Design: Randomized Controlled Studies of REACT in Participants With Type 2 Diabetes and Chronic Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
206 Care Practices for Patients Who Forgo Kidney Replacement Therapy: A National Survey of US Nephrology Providers AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
205 Predicting Hyperkalemia in Patients With Advanced Chronic Kidney Disease Using XGBoost Model AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
204 Association of CKDaP With Sleep, Depression, and Missed Sessions Among Patients on HD AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
203 Assessment and Correlation of Pruritus Scales Among Chronic In-Center Hemodialysis Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
202 The Virtual NephroTalk Experience: Learning Communication Skills During the COVID-19 Pandemic AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
201 T Wave Characteristics is the Most Sensitive ECG Change in Chronic Hemodialysis Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
200 Circadian Clock Protein Rev-Erb? as a Novel Target in CKD AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
199 A Statewide Approach to Chronic Kidney Disease Prevention and Management AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
198 Renal Dysfunction in a Patient With Alstrom Syndrome AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
197 Ob-Gyn Care, Reproductive Health Education and Lack of Knowledge in Inner-City Patients With Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
196 Longitudinal Homoral Response to SARS-CoV-2 immunization Among ESRD pts on HD in a NYC Public Hospital AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
195 Association of Financial Stressors with Medication Non-Adherence in Inner-City Patients With ESKD AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
194 Efficacy and Safety of Lumasiran in Patients with Primary Hyperoxaluria Type 1: 36-Month Analysis of the ILLUMINATE-A Trial AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
193 Evaluation of Changes in Serum FGF23 With Tenapanor Treatment in Patients With CKD on Dialysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
192 Serum Phosphorus Management in Hemodialysis (HD) Patients Who Initiated Sucroferric Oxyhydroxide (SO) as a First-line Phosphate Binder Within the First Year of HD AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
191 Hypercalcemia in Peritoneal Dialysis Patient: Management Quandaries AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
190 Cardiorenal Syndrome: CKD, Heart Failure and Risk for Dementia AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
189 Background Rates of Selected Cardiovascular (CV) Events in Non-Dialysis (ND) Patients With CKD-Related Anemia Receiving Erythropoietin-Stimulating Agents (ESAs) in the United States (US) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
188 Background Rates of Selected Cardiovascular (CV) Events in Dialysis-Dependent (DD) Patients in the United States (US) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
187 The Effects of Unconjugated p-Cresol v. p-Cresol Sulfate on Macrophage Uptake of Modified LDL AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
186 Chronic Kidney Disease and Anemia Questionnaire (CKD-AQ), a New Patient-Reported Outcomes (PRO) Measure Developed for Use in Patients With Anemia of CKD AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
185 Allograft Nephrectomy: A Management for Erythropoiesis-Stimulating Agent-Resistant Anemia in A Patient With A Failed Kidney Transplant AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
184 DISC-0974, an Anti-Hemojuvelin Antibody, Reduces Hepcidin and Mobilizes Iron in Healthy Volunteers AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
183 The Effects of Daprodustat on Blood Transfusion Rates in the ASCEND-D and -ND Trials AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
182 Red Blood Cell (RBC) Transfusion Use Varies By Baseline Hemoglobin (Hb) and Is Associated With Post-Transfusion Hyperkalemia and Hospitalization Within 30 Days in US Patients With Stage 3–5 CKD and Anemia AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
181 Protocol for the Erythropoiesis via a Novel PHI Daprodustat: Pediatric (ASCEND-P) Trial AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
303 Success Story of a Challenging Case of Refractory Lupus Nephritis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
302 Repeat Kidney Biopsies in ANCA-associated Vasculitis: Clinical and Histologic Progression AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
301 The Association Between Surrogate Kidney Endpoints and Hard Clinical Outcomes in IgA Nephropathy: A Systematic Literature Review AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
300 Determinants of Serum Potassium Levels in Patients With Chronic Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
299 Comparison of Oral Potassium Binders in Acute Hyperkalemia AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
298 Sodium Correction Rate and Clinical Parameters of Patients Treated With Proactive DDAVP Clamp for Hyponatremia: A Case Series AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
297 The Safety and Efficacy of Vaptans in the Treatment of Hyponatremia from Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): A Systematic Review and Meta-Analysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
296 Potassium Binders: A Systematic Review and Network Meta-Analysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
295 Management of Severe Hyponatremia With Modified CVVHDF AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
294 Hypomagnesemia, Renal Cysts and Uterine Agenesis due to Hepatocyte Nuclear Factor 1Beta (HNF1ß) Mutation AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
293 Extreme Hypernatremia With Masked Partial Nephrogenic Diabetes Insipidus Due to Chronic Lithium Use AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
292 Recurrence of Hyperkalemia Following Dietary Counseling, REVOLUTIONIZE I Real-World Evidence Study AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
291 Severe Hypokalemia in a Congenital Distal Renal Tubular Acidosis Case AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
290 Idiopathic Renal Phosphaturia With Incidental Finding of NPHS2 Mutation AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
289 Diagnosis and Management of Patients With Hyponatremia in the First 24 Hours Following Emergency Department Admission AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
288 Hypokalemia and Polyuria: Not Always an Occam's Razor AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
287 Improving Knowledge, Competence, and Confidence of Nephrologists and Primary Care Providers Related to Hyperkalemia With Curriculum-Based Online Education AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
286 Case-Based, Online CME Successful at Improving Management of Hyperkalemia AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
285 Renal Magnesium Wasting Post COVID-19 Infection: A Possible Unrecognized Cause of Hypomagnesemia AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
284 Check Point Inhibitor Induced Hyponatremia: A New Player Into Hyponatremia Differential Diagnosis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
283 Immune Checkpoint Inhibitor-induced Renal Tubular Acidosis and Nephrocalcinosis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
282 Hyponatremia of Cholestatic Liver Disease: ‘True' or ‘Pseudo' AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
281 Medical Costs in Patients With Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: RECOGNIZE II Study AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
280 Impact of Sodium Zirconium Cyclosilicate Plus Renin-Angiotensin-Aldosterone System Inhibitor Therapy on Short-Term Medical Costs In Hyperkalemia: OPTIMIZE II Study AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
279 A Peculiar Case of Pseudohypobicarbonatemia AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
278 RAASi Optimization Among Patients Initiating SZC, OPTIMIZE I RWE Study AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
277 Higher Risk of Progression to Albuminuria in Asian and Pacific Islander Adults With Diabetes AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
276 The Effect of Sodium-Glucose Cotransporter 2 Inhibitors, Mineralocorticoid Receptor Antagonists, and Its Combination On Albuminuria in Patients With Diabetic Nephropathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
275 Improving Care in Diabetic Kidney Disease: Bridging the Implementation Gap AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
274 Impact of KidneyIntelX Testing on Novel Medication Prescription in a Diverse Patient Population AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
273 Comparative Levels of Urinary Biomarkers of Renal Injury and Inflammation Among Patients With Diabetic Nephropathy With or Without Hyperuricemia AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
272 Monitoring Arterial-Venous Fistula Patency Using Artificial Intelligence AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
271 Ischemic Monomelic Neuropathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
270 Wearable Device for Continuous, Non-Invasive Monitoring of Access Patency in Hemodialysis Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
269 BRAG: When Does an A-V Access Need a Closer Look? AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
268 Long-Term Outcomes of Stent Grafts in Managing Thrombosed Thigh Arteriovenous Grafts AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
267 Mechanical Neobladder Dysfunction and Subclinical Pyelonephritis are the Most Common Causes of Progressive Chronic Kidney Disease After Ileal Neobladder Substitution AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
266 Race and the 2021 CKD-EPI Equations AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
265 8-Year Effects of Lifestyle Intervention on Kidney Outcomes Adjusting for Time-Updated Lean Mass AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
264 Diabetic Kidney Disease Epidemiology in US Veterans AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
263 Impact of Online CME on Knowledge of Link Between Hemodialysis and Pruritus in Patients With CKD AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
262 Current Kidney Failure Awareness and Risk Factor Control in the US Population AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
261 Association Between Spirituality and Beliefs in Medicine in a Population of Inner-City Patients with CKD/ESKD AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
260 Patiromer-Facilitated Mineralocorticoid Receptor Antagonist Use in Patients With Heart Failure and eGFR AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
259 Patient and Clinician Perspectives on the Value of Kidney Biopsies AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
258 Cancer Screening Rates in Patients With Kidney Failure on Hemodialysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
257 Time to Improvement of Itch Intensity in Patients With Chronic Kidney Disease-Associated Pruritus Treated With Difelikefalin AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
256 Lanthanum When Swallowed, Not Chewed: An Emergency Department Visit and Clinical Findings AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
255 Knowledge of Chronic Kidney Disease in Medical Providers and Its Impact on the Healthcare System AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
254 Characteristics of Finerenone Initiators Among Patients With Chronic Kidney Disease (CKD) and Type 2 Diabetes (T2D) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
253 Post-COVID Syndrome-Associated Oxidative Stress in Hemodialysis Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
252 Renal Autologous Cell Therapy (REACT) for Diabetic Chronic Kidney Disease: Phase II Trial with Bilateral Injections and Re-Dosing Triggers AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
251 Precision Medicine in Nephrology: The Role of Genetic Testing AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
250 Post Hoc Analyses of Serum Phosphate Changes With Tenapanor in Black/African American and White Patients on Maintenance Dialysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
249 An In-Depth Analysis of Serum Phosphate Changes in Patients With CKD on Dialysis: Results From the PHREEDOM Study AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
248 Binder Weight to Bind 1 Gram of Phosphate AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
247 Background Rates of Selected Non-Cardiovascular (CV) Events in Non-Dialysis (ND) Patients With Chronic Kidney Disease (CKD)-Related Anemia Receiving Erythropoiesis-Stimulating Agents (ESAs) in the United States (US) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
246 Background Rates of Selected Non-Cardiovascular (non-CV) Events of Interest in Dialysis-Dependent (DD) Patients in the United States (US) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
245 Novel Renal Autologous Cell Therapy (REACT) for Chronic Kidney Disease With Diabetes (DKD): Investigative Trial Experience in Mississippi AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
244 Kidney Failure Treatment Options and Shared Decision-Making by Ethnic Chinese: A Scoping Review AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
243 Simplified and Improved Patient Education in Chronic Kidney Disease - Medication and Disease Management: The “YOU” Project AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
365 Clinical Outcomes of Peritoneal Dialysis in Patients With Chronic Liver and Kidney Failure: A Single-Center Experience AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
364 Redefining Dialysis Care on the Hawaiian Islands: Reducing Health Disparities and Resource Utilization AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
363 Outcomes in Critical Care Admissions in Peritoneal Dialysis Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
362 Trends in Critical Care Admissions in Peritoneal Dialysis Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
361 The NxStage Hemodialysis Filter Rotator for Anticoagulation-Free Hemodialysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
360 CAPD a Good Choice for Many; Can the Culture of APD be Changed? AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
359 Home Therapies During the COVID-19 Pandemic in an Urban US Population AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
358 Sodium Thiosulfate in Peritoneal Dialysis Patients With Calciphylaxis: A Systematic Review AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
357 Achromobacter Xyxlosoxidans Peritonitis After Open Contamination in a Peritoneal Dialysis Patient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
356 Analysis of Lost Dwell Time and Cycler Alarms in Inpatient Automated Peritoneal Dialysis at a Tertiary Care Hospital AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
355 Providers Can Leverage Home Hemodialysis to Reduce Total Cost of Care in Risk-based Contracts with Medicare Advantage Organizations AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
354 Home Hemodialysis Can Help Reduce Total Cost of Care Among Medicare Advantage Members With ESRD AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
353 Variables Impacting Home Dialysis Utilization Among AKF Financial Assistance Recipients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
352 Qualitative Analysis of People With APOL1-Mediated Kidney Disease Highlights Need for Patient-Centered Educational Resources AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
351 Diagnostic Utility of Broad-Based Renal Genetic Testing in Patients With Dent Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
350 Genetic Testing for Isolated Hematuria Catalyzes Management and Cascade Testing for X-linked Alport Syndrome AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
349 Increased Imaging Burden in Patients with Autosomal Dominant Polycystic Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
348 Tesevatinib (KD019) vs Placebo for ADPKD: Results of a Ph2b Trial AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
347 Disease Burden and Disease Progression of Young Adult Patients With Autosomal Dominant Polycystic Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
346 Post-marketing Liver Safety Data from 4 Years of the Tolvaptan Risk Evaluation and Mitigation Strategy (REMS) in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
345 Mortality of Peritoneal Dialysis Patients With Liver Cirrhosis: A Systematic Review and Meta-Analysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
344 Unexpected Discoveries of Townes-Brocks Syndrome Revealed by Broad Kidney Gene Panel Testing AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
343 Autosomal Recessive Alport Syndrome With Pathogenic Variants AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
342 Bilateral Kidney Cysts and Neurodevelopmental Disorder: A Young Female With De Novo Pathogenic Variant in the NR4A2 Gene AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
341 The Impact of Genetic Test Results on Kidney Disease Diagnosis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
340 An Unusual Case of Rapidly Progressing Polycystic Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
339 Hypokalemic Hypomagnesemia in an Adult Presenting With Arrhythmia: Gitelman Syndrome? AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
338 Long-Term Sparsentan Treatment in FSGS in the DUET Open-Label Extension (OLE) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
337 ANCA-associated Necrotizing and Crescentic Glomerulonephritis Linked to Immune Checkpoint Inhibitor Durvalumab AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
336 Lenvatinib-induced Cryoglobulinemic Glomerulonephritis: It Is Never Too Late AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
335 A Case of Glomerulonephritis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
334 An Atypical Case of Seronegative Anti-GBM Disease and Concomitant IgA Nephropathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
333 Single Doses of Iptacopan Treatment Quickly Decreases Plasma Complement Bb Levels AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
332 Pharmacokinetics of Single Doses of Iptacopan AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
331 Alternative Therapy for Refractory PGNMID AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
330 Voclosporin Inhibits Calcineurin and T Cell Activation at Dose Levels Clinically Relevant for the Treatment of Lupus Nephritis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
329 Proteinuria Reduction With Sparsentan in Immunoglobulin A Nephropathy (IgAN): PROTECT Study Interim Results AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
328 Proteinuria and Disease Progression in the RaDaR IgAN Cohort AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
327 Zetomipzomib is Associated With Clinically Meaningful Reduction of Proteinuria in LN Class III/IV With or Without Class V: Post-Hoc Analysis From the Open-Label MISSION Phase 2 Study AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
326 Lupus Nephritis With Superimposed Necrotizing and Crescentic PR-3 Antineutrophil Cytoplasmatic Antibody AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
325 Plasma Exchange as an Adjunctive Therapy for Rapidly Progressive IgA Nephropathy: A Systematic Review AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
324 Rare Presentation of Monoclonal Immunoglobulin Deposition Disease in a Young Patient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
323 Efficacy of Extracorporeal Plasma Therapy for Adult Native Kidney Patients With Primary FSGS: A Systematic Review AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
322 Long-Term Sparsentan Treatment in Young Patients With FSGS in the DUET Open-Label Extension (OLE) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
321 Facing the Barriers of Renal Amyloidosis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
320 Immunoglobulin A Nephropathy Patient Reported Health Utility and Quality of Life: Evidence from US Real-World Data AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
319 Assessment of Hepatic Impairment on Iptacopan Pharmacokinetics AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
318 Assessment of Drug Interactions With Iptacopan AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
317 Case of Goodpasture syndrome With Double-Positive Anti-Glomerular Basement Membrane (GBM) and Myeloperoxidase-Anti Neutrophil Cytoplasmic Antibodies (MPO-ANCA) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
316 Rare Dual Glomerulopathy: MPO-ANCA and Secondary Membranous Nephropathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
315 A Case of Immune Checkpoint Inhibitor Associated PLA2R Membranous Nephropathy and Concurrent Acute Interstitial Nephritis Treated With Anti-CD20 Therapy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
314 Collagenofibrotic Glomerulopathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
313 Serodiagnosis of Anti-Glomerular Basement Membrane Disease Using a Newly Developed Chemiluminescence Immunoassay AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
312 Relevance of Anti-PLA2R Levels in Therapy Decision and Prediction of Therapy Outcome Using Cyclophosphamide and Steroids Treatment in Patients With Membranous Nephropathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
311 A Case of Glomerulonephritis With Dual Seropositive Autoantibodies AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
310 Treatment Considerations of Anti-GBM and ANCA Overlap Syndrome: First Do No Harm AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
309 Simultaneous Presence of MPO-ANCA Vasculitis and A Lymphoplasmacytic Lymphoma Isolated to the Bowman’s Capsule Requiring a Multidisciplinary Approach to Treatment AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
308 Primary Membranous Nephropathy Shortly After COVID-19 Vaccination AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
307 Pipeline Innovation in Glomerular Diseases AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
306 Enlight-LN: A Prospective Observational Registry of Patients Treated With Voclosporin for Lupus Nephritis in the United States AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
305 Trial in Progress: Voclosporin in Adolescents With Lupus Nephritis (VOCAL) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
304 A Case of Podocytic Infolding Glomerulopathy: A Pattern of Injury AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
431 Acetaminophen as a Renoprotective Treatment in Severe Malaria AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
430 AL Amyloidosis: Kidney Edition AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
429 Learner Perceptions of Kidney Physiology Demonstrated Through the Flipped Classroom (FC) Design for Second Year Medical Students (MS2), the University of Cincinnati Experience AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
428 Race- and Gender-Free Equation to Estimate Kidney Function in Transgender Adults AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
427 Educating Nurses on the Progression of Chronic Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
426 Disparities of Care Continue to Exist Even After Removing Race From the eGFR Calculation AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
425 ActivatEd: Activating Patients With Video Education AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
424 Kidney Biopsy Findings in Loin Pain Hematuria Syndrome in Kidney Autotransplant Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
423 Case of Heterozygous Variant of SLC2A9 Causing Urate Nephropathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
422 Advanced Practice Provider Nephrology Fellowship AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
421 Whole Body Phase Angle and Body Composition and Relationship to Frailty in Kidney Transplant Recipients (KTRs) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
420 Racial Disparity and Hypertension in Living Kidney Donors AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
419 Distinct Phenotypes of Dual Kidney Transplant Recipients in the United States as Identified Through Machine Learning Consensus Clustering AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
418 Post-Renal Acute Kidney Injury: An Overlooked Cause of Allograft Dysfunction in a Kidney Transplant Recipient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
417 Successful Outcomes in Post-Transplant Thrombotic Microangiopathy With Novel Immunosuppression Strategy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
416 NMR-based GFR Estimating Equation in Kidney Transplant Recipients Bias and Precision AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
415 The Transplant Experience for Undocumented Immigrants Formerly Receiving Emergency-Only Dialysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
414 A Case Report of Recurrent C3 Glomerulonephritis Post-COVID Infection and Vaccination AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
413 Characteristics of Kidney Recipients of High Kidney Donor Profile Index Kidneys as Identified by Machine Learning Consensus Clustering AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
412 A Case of Transplant vs Transfusion-associated Graft vs Host Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
411 Donor-Derived Strongyloides Stercolis Infection in a Kidney Transplant Recipient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
410 Racial and Ethnic Differences in Inpatient Mortality in Kidney Transplant Recipients with COVID-19 Infection: a Nationally Representative Study AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
409 Renal Transplant Transition Rates After Neurocognitive Evaluation in ESRD AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
408 Knowledge and Attitudes of Health Care Professionals in the Intensive Care Unit (ICU), Haemodialysis Unit (HDU), and Accident and Emergency Department (A&E) at a Teaching Hospital Toward Organ (Kidney) Donation and Transplantation AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
407 Monosodium Urate Crystal Depletion in Renal Transplant Recipients Treated With Pegloticase: PROTECT Serial Dual-Energy Computed Tomography Findings AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
406 Malakoplakia: A Case Report of a Rare Granulomatous Condition Afflicting a Renal Transplant Recipient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
405 Cytomegalovirus Gastroparesis After Kidney Transplantation: A Case Report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
404 2, 8 Dihydroxyadenine Kidney Allograft Crystallopathy Recurrence in Kidney Transplantation AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
403 Curious Case of Acute Interstitial Nephritis in Kidney Transplant: Association With Red Meat Allergy? AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
402 The Curious Case of Lung Mass in a Renal Transplant Recipient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
401 Successful Treatment of Thrombotic Microangiopathy Due to Acute Antibody Mediated Rejection of Kidney Transplant AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
400 Belatacept Based Immunosuppression in Patient With Combined Heart and Kidney Transplant: A Case Report AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
399 Double Trouble: Recurrence of Membranous Nephropathy in a Liver-Kidney Transplant Patient AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
398 Effect of Overhydration in Energy Expenditure in Chronic Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
397 Evaluating Dietitian Implementation of Renal Nutrition Guideline Recommendations AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
396 Home-Delivered Meal Engagement Among Hemodialysis Patients in the Denver Metro AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
395 Effectiveness of Short-term, Home-delivered, Low Sodium Meals to Sustain Long-term Changes in Dietary Behavior in Hemodialysis Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
394 Changes in Gut-Derived Uremic Toxins With Dietary CKD Counseling AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
393 Impact of Intra-Dialytic Meals During In-Center Hemodialysis Treatment on Depressive Symptoms: Findings From the FrEDI Randomized Controlled Trial AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
392 Effect of Vitamin D Supplementation on Dialysis Patients' Serum Vitamin D Levels: Systematic Review AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
391 Correlation between physical function and physical activity with muscle mass measured with computed tomography in adults’ hemodialysis patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
390 Comparison of Body Composition Measurements in Patients With Chronic Kidney Disease Receiving Maintenance Hemodialysis Using Bioelectrical Impedance Analysis and Anthropometric Equations AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
389 Factors Associated With Seeing a registered Dietitian Among a Representative Sample of People in the United States With Chronic Kidney Disease: An Analysis of Data from CKDopps AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
388 Efficacy of Fortified Synbiotic Dessert on Malnutrition and Oxidative Stress Outcomes in Hemodialysis Patients: A Randomized Double-Blind Controlled Trial AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
387 Design and Implementation of a Renal Plant-Based Cooking Demonstration AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
386 Phosphorus and Aluminum Content of Wheat Flour Tortillas Exceeds That of Corn (Maize) Tortillas: Dietary Implications for Patients With Renal, Cardiovascular or Neurological Diseases AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
385 Effects of Mediterranean Diet, DASH Diet, and Plant-based Diet on Outcomes Among End Stage Kidney Disease Patients AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
384 Phosphorus Bioaccessibility of Milk and Beef Plant-Based Protein Alternative Products Using In Vitro Simulation of Human Digestion AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
383 Associations of Skeletal Muscle Mass Index and Protein Markers in Patients With Stage 5 Chronic Kidney Disease Receiving Maintenance Hemodialysis AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
382 Advanced Practice ESRD Hospital Care AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
381 Experience of Starting a Rural Home Hemodialysis Program AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
380 Animal-assisted Intervention for Hemodialysis Patients’ Treatment Adherence, Pain, and Depression AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
379 To Tunnel or Not to Tunnel a Catheter for Kidney Replacement Therapy in the Medical ICU: Role of an Advanced Hemodialysis Vascular Access Team AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
378 Advance Care Planning (ACP) for ESKD Patients in a Single Center Hemodialysis Clinic in the Veteran’s Hospital AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
377 Strategies to Optimize Transplant Referral Readiness and Increase Referrals: An Interdisciplinary Approach AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
376 American Kidney Fund Health Equity Coalition: Interprofessional Collaboration Addressing Four Domains of Racial Disparities in Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
375 An Interprofessional Approach to Medication Renal Dose Adjustment in a Family Medicine Clinic AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
374 A Scoping Review of the Pharmacist’s Role in Post-Discharge Care for Patients With Kidney Disease AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
373 Primary Care Provider Perceptions of a Population Health Management Program to Improve Kidney Care AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
372 A Retrospective Multisite Examination of Chronic Kidney Disease Using Longitudinal Laboratory Results and Metadata to Inform Value Based Care AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
371 Hypertension Medications Daily Dose Usage Trend and Blood Pressure Control from 2012-2020 in a Large U.S. Health System AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
370 Influence of Baseline Depressive Symptoms on the Effect of BP Intervention on Cognitive Outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
369 Depressive Symptoms and Achieving BP Goals in the Systolic Blood Pressure Intervention Trial (SPRINT) AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
368 Primary Aldosteronism Presenting During Pregnancy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
367 Looking Beyond Hypertension: A Case of Complement-Mediated Thrombotic Microangiopathy AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
366 Patient Preference for Peritoneal Dialysis and Modality Utilized Among a Late-Stage Chronic Kidney Disease Population in Bronx, NY AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
Support Page AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
Table of Contents AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
Editorial Board AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
Masthead AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
436 Can Muscle Mass Explain the Relationship Between eGFRDiff (=eGFRCys–eGFRCr) and Frailty in Older Men? AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
435 Evaluation of Perceived Preparedness: A Nationwide Survey of Incoming Nephrology Fellows AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
434 Initiative for Appropriate Diabetic Kidney Disease Screening With Yearly UACR and eGFR Testing in the Primary Care Setting AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
433 Work Hours in Fellowship and Early Career Nephrology: Perception versus Actual Recorded EMR Screen Time AJKD

(American Journal of Kidney Diseases 81, 4 (2023))
10:30
432 Gender Biases in Nephrology: A 2022 Survey of Female Nephrologists AJKD

(American Journal of Kidney Diseases 81, 4 (2023))

J Human Hypertens http://www.nature.com/jhh/

00:00
Flawed research methods result in misleading conclusions - Rachael M. McLean, Feng J. He, Graham A. MacGregor J Human Hypertens

Journal of Human Hypertension, Published online: 21 March 2023; doi:10.1038/s41371-023-00818-wFlawed research methods result in misleading conclusions (Journal of Human Hypertension, Published online: 2023-03-21; | doi:10.1038/s41371-023-00818-w)

Eur Heart J https://academic.oup.com/site_5375/

01:00
New light shed on syncope and sudden cardiac death Eur Heart J

20 March

Stroke https://www.ahajournals.org/

10:00
Large Vessel Occlusion Stroke due to Intracranial Atherosclerotic Disease: Identification, Medical and Interventional Treatment, and Outcomes - Adam de Havenon Osama O. Zaidat Sepideh Amin-Hanjani Thanh N. Nguyen Aaron Bangad Mehdi Abbasi Mohammad Anadani Eyad Almallouhi Rano Chatterjee Mikael Mazighi Eva A. Mistry Shadi Yaghi Colin P. Derdeyn Keun-Sik Hong Alexandra Kvernland Thabele M. Leslie-Mazwi Sami Al Kasab Neurology, Yale University, New Haven, CT (A.d.H., A.B., M.A.). Neurology, Mercy Health, Toledo, OH (O.O.Z.). Neurosurgery, UH Cleveland Medical Center, OH (S.A.-H.). Neurology, Boston Medical Center, MA (T.N.N.). Neurology, Medical University of South Carolina, Charleston (M.A., E.A., S.A.K.). Radiology, Washington (...) Stroke

Stroke, Ahead of Print. Large vessel occlusion stroke due to underlying intracranial atherosclerotic disease (ICAD-LVO) is prevalent in 10 to 30% of LVOs depending on patient factors such as vascular risk factors, race and ethnicity, and age. Patients with ICAD-LVO derive similar functional (...) (Stroke)

Circulation http://ahajournals.org/

10:00
Effectiveness of the Family Heart Talk Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial - Daniel D. Kinnamon Elizabeth Jordan Garrie J. Haas Mark Hofmeyer Evan Kransdorf Gregory A. Ewald Alanna A. Morris Anjali Owens Brian Lowes Douglas Stoller W.H. Wilson Tang Sonia Garg Barry H. Trachtenberg Palak Shah Salpy V. Pamboukian Nancy K. Sweitzer Matthew T. Wheeler Jane E. Wilcox Stuart Katz Stephen Pan Javier Jimenez Keith D. Aaronson Daniel P. Fishbein Frank Smart Jessica Wang Stephen S. Gottlieb Daniel P. Judge Charles K. Moore Jonathan O. Mead Gordon S. Huggins Hanyu Ni Wylie Burke Ray E. Hershberger Department of Internal Medicine, Division of Human Genetics, the Ohio State (...) Circulation

Circulation, Ahead of Print. BACKGROUND:Managing disease risk among first-degree relatives of probands diagnosed with a heritable disease is central to precision medicine. A critical component is often clinical screening, which is particularly important for conditions like dilated (...) (Circulation)

Can J Kidney Health Dis https://journals.sagepub.com/toc/cjka/9

09:41
Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research Protocol - Kevin Yau, Omosomi Enilama, Adeera Levin, Marc G. Romney, Joel Singer, Peter Blake, Jeffrey Perl, Jerome A. Leis, Robert Kozak, Hubert Tsui, Shelly Bolotin, Vanessa Tran, Christopher T. Chan, Paul Tam, Miten Dhruve, Christopher Kandel, Jose Estrada-Codecido, Tyler Brown, Aswani Siwakoti, Kento T. Abe, Queenie Hu, Karen Colwill, Anne-Claude Gingras, Matthew J. Oliver, Michelle A. Hladunewich Can J Kidney Health Dis

Canadian Journal of Kidney Health and Disease, Volume 10, Issue , January-December 2023. Background:People living with chronic kidney disease (CKD) have been disproportionately affected by the coronavirus disease 2019 (COVID-19) pandemic, including higher rates of infection, hospitalization, (...) (Canadian Journal of Kidney Health and Disease)

Diabetes https://diabetes.diabetesjournals.org

01:00
A Special Thanks to the Reviewers of Diabetes Diabetes

Diabetes calls on thousands of scientific and medical experts each year to review manuscript submissions. The editors of Diabetes sincerely appreciate the efforts of all of our reviewers who volunteer their time and expertise to provide valuable feedback to ensure the consistently high quality (...)
01:00
Issues and Events Diabetes
01:00
In This Issue of Diabetes Diabetes
01:00
Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases: Workshop Proceedings Diabetes

The Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases workshop was a 1.5-day scientific conference at the National Institutes of Health (Bethesda, MD) that engaged clinical and basic science investigators interested in diseases of the pancreas. This report (...)

Kidney Int http://www.kidney-international.org/

00:00
From bench to bedside: Lessons learned from translational podocyte research - Olivia Lenoir, Tobias B. Huber, Pierre-Louis Tharaux Kidney Int

Polat et al. report that mice with a podocyte-specific expression of a constitutively-active Rac1 form displayed similar injury and albuminuria, irrespectively of Transient Receptor Potential Canonical 5 (TRPC5) activity. This article confirms the pathogenic role of deregulated Rac1 and (...) (Kidney International (2023))

Br Med J (BMJ) http://www.bmj.com/

12:36
First hepatitis D medicine is given restricted approval in Scotland after US rejection - Elisabeth Mahase Br Med J (BMJ)

Scotland has become the first country in the UK to approve a specific treatment for the hepatitis delta virus (HDV), after it granted bulevirtide (Hepcludex) “restricted use” approval for patients with chronic infection and compensated liver disease.1The drug (2 mg powder for injection) will be (...) -- Infectious diseases, UK
12:31
US state legislators propose death penalty for women who have an abortion - Janice Hopkins Tanne Br Med J (BMJ)

Republican legislators in South Carolina have proposed a bill to change the state’s laws, making a fertilised egg or embryo a person and charging a woman who has an abortion with murder, which carries a 30 year prison sentence or the death penalty.1 Henry McMaster, the state’s Republican (...)
12:30
Junior doctor strike led to 175 000 postponements, data show - Gareth Iacobucci Br Med J (BMJ)

More than 175 000 planned hospital appointments and procedures were postponed during last week’s 72 hour strike by junior doctors, show official data from NHS England.1The release of the figures came as BMA leaders agreed to meet England’s health and social care secretary, Steve Barclay, this (...)
12:21
Covid-19: US maternal mortality rose during pandemic - Janice Hopkins Tanne Br Med J (BMJ)

Two studies show that maternal mortality in the US dramatically increased during the covid-19 pandemic and was especially severe among racial and ethnic minorities and in rural areas and small cities.12The US already has the worst maternal mortality rate among industrialised countries. The (...) -- COVID-19
12:06
Gene editing: China’s new regulations contain concerning loopholes, experts warn - Elisabeth Mahase Br Med J (BMJ)

China’s new ethics regulations are a step in the right direction in terms of overseeing gene editing research, but there are concerns that private ventures may not be covered.Joy Zhang, founding director of the Centre for Global Science and Epistemic Justice at the University of Kent, said that (...)
10:31
GP training overhaul aims to boost flexibility, breadth, and quality of training - Adrian O’Dowd Br Med J (BMJ)

GP trainees should be offered better and broader training alongside enhancements to their knowledge of technology, health inequalities, and areas of care such as mental health, says a report from Health Education England (HEE).1The report on HEE’s vision for the future of general practice (...)
09:06
Trust and transformation: an agenda for creating resilient and sustainable health systems - Hans Kluge, Natasha Azzopardi-Muscat, Josep Figueras, Martin McKee Br Med J (BMJ)

Health systems are facing unprecedented challenges as they emerge from the covid-19 pandemic. How they have responded has varied greatly. Just as with SARS in 2003, when some Asian health systems redesigned facilities to be better prepared for a future pandemic,1 we have seen new ways of (...)

Kidney Int http://www.kidney-international.org/

11:46
Table of Contents Kidney Int

(Kidney International 103, 4 (2023))
11:46
Subscription Information Kidney Int

(Kidney International 103, 4 (2023))
11:46
Editorial Board Kidney Int

(Kidney International 103, 4 (2023))
11:46
Acknowledgment of reviewers Kidney Int

The Editors are grateful to the following Reviewers who evaluated manuscripts for Kidney International during 2022. (Kidney International 103, 4 (2023))
11:46
journal club Kidney Int

Takahashi et al., on behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention; Council on Hypertension; Council on the Kidney in Cardiovascular Disease; and Stroke Council. (Circulation. 2022;146:e558–e568.) (Kidney International 103, 4 (2023))
11:46
in this issue Kidney Int

The Jaffe reaction is the most commonly used test to measure creatinine levels. High levels of glucose can interfere with Jaffe, causing it to overestimate creatinine. Because the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors (SGLT2i) is increasing dramatically in patients with (...) (Kidney International 103, 4 (2023))
11:46
Glucocorticoids for IgA nephropathy—pro - Yue-Miao Zhang, Ji-Cheng Lv, Muh Geot Wong, Hong Zhang, Vlado Perkovic Kidney Int

Since IgA nephropathy (IgAN) was first described in 1968 by Jean Berger, supportive lifestyle measures and blood pressure lowering agents, especially renin-angiotensin system inhibitors (RASi), have become first-line treatment. Despite this, a substantial risk of progression remains even when (...) (Kidney International 103, 4 (2023))
11:46
First do no harm: systemic glucocorticoids should not be used for the treatment of progressive IgA nephropathy - Chee Kay Cheung, Jonathan Barratt Kidney Int

Over recent years, significant progress has been made in the understanding of the pathogenesis of IgA nephropathy (IgAN). A multihit model is widely accepted; in patients with IgAN, there is an increase in circulating poorly galactosylated IgA1, likely to be of mucosal origin, that drives (...) (Kidney International 103, 4 (2023))
11:46
IgA nephropathy and glucocorticoids—a limbo dance? - Brad H. Rovin Kidney Int

In this issue of Kidney International, arguments are presented for and against the use of systemic glucocorticoids (GCs) in the treatment of IgA nephropathy (IgAN) that is likely to progress. The use of immunomodulation in IgAN makes sense. The immune system, especially the mucosal immune (...) (Kidney International 103, 4 (2023))
11:46
Advances in biodesign: artificial water channels outperforming aquaporins - Ines P.D. Costa, Iain A. Drummond, Olivier Devuyst Kidney Int

Water channels mediating fast water transport across biological membranes are essential for water balance in all living organisms. The archetypal water channel, aquaporin-1 (AQP1), was cloned from human erythrocytes by Denker et al. in the late 1980s,1 and its function was demonstrated by a (...) (Kidney International 103, 4 (2023))
11:46
Corrigendum to “Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury.” Kidney Int. 2022;101:79–91 - Yu Pan, Shirong Cao, Andrew S. Terker, Jiaqi Tang, Kensuke Sasaki, Yinqiu Wang, Aolei Niu, Wentian Luo, Dhouha Daassi, Xiaofeng Fan, Suwan Wang, Matthew H. Wilson, Ming-Zhi Zhang, Raymond C. Harris Kidney Int

The authors of the above-stated article regret the misspelled name of the author Dhouha Daassi. (Kidney International 103, 4 (2023))
11:46
Novel mechanism of increased preeclampsia risk after kidney donation - Elizabeth Ann L. Enninga, Vesna D. Garovic Kidney Int

Preeclampsia is a hypertensive disorder of pregnancy diagnosed after 20 weeks of gestation in the presence of maternal elevated blood pressures accompanied by proteinuria or organ dysfunction, including kidney insufficiency. Although low-dose aspirin is recommended for preeclampsia prevention (...) (Kidney International 103, 4 (2023))
11:46
Solving the insoluble: calciprotein particles mediate bulk mineral transport - Willi Jahnen-Dechent, Andreas Pasch Kidney Int

Protein mineral complexes, or calciprotein particles, are formed by calcium, phosphate, and the plasma protein fetuin-A. Crystalline calciprotein particles cause soft tissue calcification, oxidative stress, and inflammation, all well-known complications in chronic kidney disease. The T50 (...) (Kidney International 103, 4 (2023))
11:46
Kidney-specific metabolomic profiling in machine perfusate - Eugene P. Rhee Kidney Int

Given their accessibility and relevance to established clinical workflows, blood and urine have been the major focus of investigation in metabolomics studies of human kidney disease. In this issue, Liu et al. describe the application of metabolomics to perfusate from donor kidneys subjected to (...) (Kidney International 103, 4 (2023))
11:46
A transitional B-cell cytokine biomarker for risk stratifying renal transplant patients with borderline rejection - Sumoyee Basu, Anthony Dorling, Anita S. Chong Kidney Int

Borderline allograft rejection can promote acute rejection and graft loss in some, but not all, patients. In this issue, Cherukuri et al. use a novel test based on peripheral blood transitional T1 B cells producing interleukin-10 and tumor necrosis factor-?, which identifies patients at high (...) (Kidney International 103, 4 (2023))
11:46
Fosl1: friend or foe? - Shruti Bhargava, Joachim Jankowski Kidney Int

Fos-like antigen 1 (Fosl1) is a protein that belongs to the Fos family of transcription factors. Fosl1 has an impact on (i) carcinogenesis, (ii) acute kidney injury, and (iii) fibroblast growth factor expression. Recently, the nephroprotective effect of Fosl1 by the preservation of Klotho (...) (Kidney International 103, 4 (2023))
11:46
Pulmonary-renal syndrome in IgA vasculitis - Sascha T. Bender, Peter R. Mertens, Christian Gross Kidney Int

A 65-year old man was admitted with acute kidney failure, respiratory difficulty, and hemoptysis. He had a medical history of chronic kidney disease stage 3A. He noted a skin rash starting 4 days before admission, accompanied by arthralgia affecting both knees and ankles, abdominal pain, and (...) (Kidney International 103, 4 (2023))
11:46
Spheroplasts in the urinary sediment - Giovanni Battista Fogazzi, Giuseppe Garigali Kidney Int

A 33-year-old woman, who 4 months before had received a cadaveric kidney transplant for end-stage kidney disease caused by chronic pyelonephritis, was seen in clinic for routine follow-up. The patient was asymptomatic and was receiving treatment with anti-rejection medications and oral cefixime (...) (Kidney International 103, 4 (2023))
11:46
The Case | Hematuria and hypercalcemia in a kidney transplant recipient - Athiphat Banjongjit, Thunyatorn Wuttiputhanun, Jakapat Vanichanan, Thornthun Ueaphongsukkit, Kroonpong Iampenkhae, Yingyos Avihingsanon, Natavudh Townamchai Kidney Int

A 25-year-old woman presented with dysuria and intermittent gross hematuria for 2 weeks. She underwent a kidney transplantation 2 years earlier because of end-stage kidney disease of unknown cause. She received basiliximab as induction therapy, followed by maintenance immunosuppression with (...) (Kidney International 103, 4 (2023))

19 March

Kidney Int Reports http://www.kireports.org/

00:00
National Trends in Complications of Vascular Access for Hemodialysis and Analysis of Racial Disparities among Patients with End-Stage Renal Disease in the Inpatient Setting - Waseem Wahood, Edwin Takahashi, Dheeraj Rajan, Sanjay Misra Kidney Int Reports

To assess the trends in access-related complications, as well as the impact of race on these complications, among admitted end-stage kidney disease (ESKD) patients receiving hemodialysis. (Kidney International Reports (2023))

18 March

Diabetologia http://link.springer.com/

00:00
Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to reduce the incidence of gestational diabetes and type 2 diabetes Diabetologia

Abstract Aims/hypothesis The aim of this study was to determine the long-term cost-effectiveness and return on investment of implementing a structured lifestyle intervention to reduce excessive gestational weight gain and associated incidence of gestational diabetes mellitus (GDM) and type 2 (...)

AJKD https://www.ajkd.org/

00:00
Fructose: A New Variable to Consider in SIADH and the Hyponatremia Associated With Long-Distance Running? - Richard J. Johnson, S-M Kurt Lee, Laura G. Sánchez-Lozada, Mehmet Kanbay, Anip Bansal, Dean R. Tolan, Petter Bjornstad, Miguel A. Lanaspa, John Maesaka AJKD

Fructose has recently been proposed to stimulate vasopressin secretion in humans. Fructose-induced vasopressin secretion is not only postulated to result from ingestion of fructose-containing drinks, but may also occur from endogenous fructose production via activation of the polyol pathway. (...) (American Journal of Kidney Diseases (2023))

Kidney Int http://www.kidney-international.org/

00:00
Podocyte protease actuated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events. - Carl J May, Musleeha Chesor, Sarah E Hunter, Bryony Hayes, Rachel Barr, Tim Roberts, Fern A Barrington, Louise Farmer, Lan Ni, Maisie Jackson, Heidi Snethen, Nadia Tavakolidakhrabadi, Max Goldstone, Rodney Gilbert, Matt Beesley, Rachel Lennon, Rebecca Foster, Richard Coward, Gavin I Welsh, Moin A Saleem Kidney Int

About 30% of patients who have a kidney transplant with underlying nephrotic syndrome (NS) experience rapid relapse of disease in their new graft. This is speculated to be due to a host-derived circulating factor acting on podocytes, the target cells in the kidney; leading to focal segmental (...) (Kidney International (2023))
00:00
PROTEINURIA AND HEMATURIA AFTER REMISSION INDUCTION ARE ASSOCIATED WITH OUTCOME IN ANCA-ASSOCIATED VASCULITIS - Nicolas Benichou, Pierre Charles, Benjamin Terrier, Rachel B Jones, Thomas Hiemstra, Luc Mouthon, Ingeborg Bajema, Annelies Berden, Eric Thervet, Loïc Guillevin, David Jayne, Alexandre Karras, French Vasculitis Study Group (FVSG) and European Vasculitis Society (EUVAS) investigators Kidney Int

In anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), hematuria and proteinuria are biomarkers reflecting kidney involvement at diagnosis. Yet, the prognostic value of their persistence after immunosuppressive induction therapy, reflecting kidney damage or persistent (...) (Kidney International (2023))

Kidney Int Reports http://www.kireports.org/

00:00
Association of the Kidney Failure Risk Equation with High Healthcare Costs - Nancy L. Reaven, Susan E. Funk, Vandana Mathur, Thomas W. Ferguson, Julie Lai, Navdeep Tangri Kidney Int Reports

The Kidney Failure Risk Equations (KFRE) are accurate and validated to predict the risk of kidney failure in individuals with chronic kidney disease (CKD), but their potential to predict healthcare costs in the US healthcare system is unknown. We assessed the association of kidney failure risk (...) (Kidney International Reports (2023))
00:00
Safety and Diagnostic Yield of Protocolized Percutaneous Kidney Biopsies in Mechanically Ventilated Patients with Acute Kidney Injury - Christopher Estiverne, Gearoid M. McMahon, David B. Mount, Giada Bianchi, Carol Daddio Pierce, Hasna Hakim, Helmut G. Rennke, Peter G. Czarnecki Kidney Int Reports

Research Letter: (Kidney International Reports (2023))

Lancet https://www.thelancet.com/journals/lancet

00:00
[Editorial] Human genome editing: ensuring responsible research - The Lancet Lancet

In 2018, during the Second International Summit on Human Genome Editing in Hong Kong, Jiankui He shocked the world by announcing the birth of two children whose genomes he had edited using CRISPR technology. Following widespread condemnation and a criminal investigation, he was sentenced to 3 (...) (The Lancet 401, 10380 (2023))
00:00
[Comment] Offline: The silencing of the South - Richard Horton Lancet

League tables are addictive. From football to motorsport, tennis to golf, we relish following who is up and who is down. Understandably so, given that sport is fiercely competitive between individuals and teams. But universities? Provosts and Presidents of our greatest higher education (...) (The Lancet 401, 10380 (2023))
00:00
[World Report] Global health experts welcome Kasai dismissal - John Zarocostas Lancet

WHO's dismissal of Takeshi Kasai, Regional Director for the Western Pacific, could pressure WHO leadership to take decisive action in other misconduct cases. John Zarocostas reports from Geneva. (The Lancet 401, 10380 (2023))
00:00
[World Report] Health and the invasion of Iraq: 20 years later - Shawn Yuan Lancet

The legacy of the US-led invasion is still being felt across Iraqi society. Shawn Yuan reports from Baghdad. (The Lancet 401, 10380 (2023))
00:00
[World Report] “Impunity” enabling South Sudan human rights violations - John Zarocostas Lancet

A new report to the UN Human Rights Council outlines how violence is worsening health and humanitarian programmes. John Zarocostas reports from Geneva. (The Lancet 401, 10380 (2023))
00:00
[Perspectives] Aftermath of the Türkiye–Syria earthquake - Danielle Villasana Lancet

The earthquakes in Türkiye and Syria on Feb 6, 2023, will have lasting health and humanitarian impacts. Current estimates indicate more than 50 000 people have died and over 100 000 people have been injured. Thousands of buildings and much infrastructure are destroyed, with millions of people (...) (The Lancet 401, 10380 (2023))
00:00
[Obituary] Samuel Lawrence Katz - Geoff Watts Lancet

Paediatrician, virologist, and co-developer of measles vaccine. Born in Manchester, NH, USA, on May 29, 1927, he died in Chapel Hill, NC, USA, on Oct 31, 2022 aged 95 years. (The Lancet 401, 10380 (2023))
00:00
[Correspondence] We cannot erase Syrians' suffering with “solidarity” and political infighting - Mouna Khaity, Mervat Alhaffar, Natasha Howard Lancet

“The UN's failure to act quickly to save Syrian lives in the face of a humanitarian catastrophe is utterly shameful and should be a stain on its conscience.”1 Raed Al Saleh, The White Helmets (The Lancet 401, 10380 (2023))
00:00
[Correspondence] Error in NHS England's BMI calculator and daily calorie recommendations - Stuart W Flint Lancet

BMI is a calculation of height and weight to identify a person's weight status.1 BMI is calculated by a person's weight in kilograms (or pounds) divided by the square of height in metres (or feet).1 The BMI ranges are underweight (...) (The Lancet 401, 10380 (2023))
00:00
[Correspondence] Firearms and blood transfusion: an inescapable disentanglement - Jeremy W Jacobs, Laura D Stephens, Jennifer S Woo, Elizabeth S Allen, Garrett S Booth Lancet

The incidence of mass shootings in the USA continues to increase; more than 45 000 total gun deaths occurred in 2020 alone, the most on record for years with full data available.1 These statistics highlight increasing gun violence, one of the primary contributors to blood shortages. Patients (...) (The Lancet 401, 10380 (2023))
00:00
[Correspondence] Chlordecone (Kepone) poisoning in the French Territories in the Americas - Dabor Resiere, Jonathan Florentin, Hatem Kallel, Rishika Banydeen, Ruddy Valentino, Moustapha Dramé, José-Louis Barnay, Papa Gueye, Bruno Mégarbane, Hossein Mehdaoui, Rémi Neviere, Toxicological Research Group on chlordecone at the University Hospital of Martinique Lancet

For more than 40 years, two French territories in the Americas, Martinique and Guadeloupe, have been confronted with one of the biggest environmental scandals in Caribbean history due to the use of an organochlorine pesticide, chlordecone (also known under the brand name Kepone), in banana (...) (The Lancet 401, 10380 (2023))
00:00
[Department of Error] Department of Error Lancet

Purba AK, Henderson M, Baxter A, Pearce A, Katikireddi SV. To what extent does time spent on social media influence adolescent use of cigarettes and e-cigarettes: a longitudinal analysis of the UK Millennium Cohort Study. Lancet 2022; 400: S73—In this Meeting Abstract, the reference category (...) (The Lancet 401, 10380 (2023))
00:00
[Department of Error] Department of Error Lancet

Schöley J, Karlinsky A, Kobak D, Tallack C. Conflicting COVID-19 excess mortality estimates. Lancet 2023; 401: 431–32—The appendices of this Correspondence have been updated as of March 16, 2023. (The Lancet 401, 10380 (2023))
00:00
[Clinical Picture] A urinary tract infection caused by Escherichia coli mucoid phenotype progresses to a pneumonia and respiratory failure - Federica Quarata, Diana Lelli, Davide Maria Biancone, Giovanni Gherardi, Raffaele Antonelli Incalzi Lancet

A 69-year-old woman was admitted to our ward with fever and respiratory failure. 3 weeks earlier she had been treated with ciprofloxacin for a urinary tract infection, caused by Escherichia coli; she had a history of diabetes. (The Lancet 401, 10380 (2023))

17 March

J Clin Hypertens http://onlinelibrary.wiley.com//journal/10.1111/(ISSN)1751-7176

13:14
Association between triglyceride glucose?body mass index and hypertension in Chinese adults: A cross?sectional study - Danying Deng, Chaolei Chen, Jiabin Wang, Songyuan Luo, Yingqing Feng J Clin Hypertens

The Journal of Clinical Hypertension, EarlyView. -- ORIGINAL ARTICLE (Wiley: The Journal of Clinical Hypertension: Table of Contents)
12:18
Clinical characteristics and outcomes of Chinese patients with coronary heart disease and resistant hypertension - Binbin Zhu, Yahui Liu, Weicen Zhou, Yao Du, Datun Qi, Chenxu Wang, Qianqian Cheng, You Zhang, Shan Wang, Chuanyu Gao J Clin Hypertens

The Journal of Clinical Hypertension, EarlyView. -- ORIGINAL ARTICLE (Wiley: The Journal of Clinical Hypertension: Table of Contents)

J Am Heart Assoc https://www.ahajournals.org/feeds.jsp

11:28
A Longitudinal Study of Acculturation in Context and Cardiovascular Health and Their Effects on Cognition Among Older Latino Adults - Melissa Lamar, Mayra L. Estrella , Ana W. Capuano , Sue Leurgans , Debra A. Fleischman , Lisa L. Barnes , Brittney S. Lange?Maia , David A. Bennett , and David X. Marquez 1 Rush Alzheimer’s Disease Center Rush University Medical Center Chicago IL 2 Department of Psychiatry and Behavioral Sciences Rush University Medical Center Chicago IL 3 Department of Epidemiology, Human Genetics and Environmental Sciences University of Texas Health Science Center at Houston School of Public Health Brownsville TX 4 Department of Neurological Sciences Rush University Medical Center Chicago IL 5 Department (...) J Am Heart Assoc

Journal of the American Heart Association, Ahead of Print. BackgroundWe previously outlined the importance of considering acculturation within the context of older Latino adults' lived experience (ie, acculturation in context) to better capture contributors to cognitive aging. We now examine (...) (Journal of the American Heart Association)

Articles récents

Préférences

Sources

Accueil du site

permalink

21 March

AJKD https://www.ajkd.org/

J Human Hypertens http://www.nature.com/jhh/

Eur Heart J https://academic.oup.com/site_5375/

20 March

Stroke https://www.ahajournals.org/

Circulation http://ahajournals.org/

Can J Kidney Health Dis https://journals.sagepub.com/toc/cjka/9

Diabetes https://diabetes.diabetesjournals.org

Kidney Int http://www.kidney-international.org/

Br Med J (BMJ) http://www.bmj.com/

Kidney Int http://www.kidney-international.org/

19 March

Kidney Int Reports http://www.kireports.org/

18 March

Diabetologia http://link.springer.com/

AJKD https://www.ajkd.org/

Kidney Int http://www.kidney-international.org/

Kidney Int Reports http://www.kireports.org/

Lancet https://www.thelancet.com/journals/lancet

17 March

J Clin Hypertens http://onlinelibrary.wiley.com//journal/10.1111/(ISSN)1751-7176

J Am Heart Assoc https://www.ahajournals.org/feeds.jsp